Transurethral microwave therapy (TUMT) for benign prostatic hyperplasia

References

Citations

1. Webber R (2005). Benign prostatic hyperplasia. Clinical Evidence (14): 1076–1091.

2. Fitzpatrick JM, Mebust WK (2002). Minimally invasive and endoscopic management of benign prostatic hyperplasia. In PC Walsh et al., eds., Campbell's Urology, 8th ed., vol. 2, pp. 1379–1422. Philadelphia: W.B. Saunders.

3. U.S. Food and Drug Administration (2002). Microwave therapy warning. JAMA, 284(21): 2711.

Author:	Douglas Dana Ralph Poore	Last Updated: August 30, 2006
Medical Review:	Martin Gabica, MD - Family Medicine Adam Husney, MD - Family Medicine J. Curtis Nickel, MD, FRCSC - Urology Christopher G. Wood, MD, FACS - Urology/Oncology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.